This responsemay occur because, at certain concentrations, heparin could bridgethe interactions between SP and CD147, making the binding more effective.Further characterization of the heparin-binding properties could potentiallyhelp develop more comprehensive treatments for COVID-19. This evidence concerns the gene BSG and COVID-19.